Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred? [electronic resource]

By: Contributor(s): Producer: 20210127Description: 1757-1759 p. digitalISSN:
  • 1527-7755
Subject(s): Online resources: In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Editorial; Research Support, N.I.H., Extramural; Comment

There are no comments on this title.

to post a comment.